Remove 2016 Remove Career Remove Finance Remove Human Resources
article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

Roivant was addressing some sobering realities: In 2016, only 22 new drugs were approved by the U.S. While virtually all pharma companies say they encourage risk, in reality the failure of individual drug-development programs frequently results in career damage or even job loss for the research teams involved.

article thumbnail

Ageism in the Workplace: Laws and Resources for Employees

HR Digest

It is the mid-segment executives that were handling the finance, accounting, sales, and administrative jobs that are finding themselves left out in the cold with applications softwares taking over their careers. Co-workers who have hit the mid 40s have had their career stalled.